CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2011	Sep. 30, 2010	Sep. 30, 2011	Sep. 30, 2010
Cash Flows From Operating Activities
Net income (loss)	$ 40,862	$ (207,882)	$ 103,704	$ (177,063)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	154,936	42,338	404,214	122,619
Amortization of deferred revenue	(4,775)	(4,775)	(14,326)	(14,326)
Amortization of discounts on long-term debt	1,917	2,712	6,504	8,350
Amortization and write-down of deferred financing costs	10,768	6,854	12,529	9,498
Share-based compensation	17,587	68,284	73,038	71,836
Tax benefits from stock options exercised	(2,042)		(33,658)
Deferred income taxes	(38,601)	59,500	(77,098)	64,500
Acquired in-process research and development			4,000	61,245
Acquisition-related contingent consideration	6,904		9,042
Allowances for losses on accounts receivable and inventories	1,740	(636)	4,212	(390)
Acquisition accounting adjustment on inventory sold	2,768		48,939
Non-cash cost of alliance revenue			30,686
Payment of accrued legal settlements			(16,400)	(5,950)
Additions to accrued legal settlements		38,500	400	38,500
Loss on extinguishment of debt	10,315		33,325
Payment of accreted interest on repurchase of convertible debt	(3,362)		(8,363)
Gain on sale of marketable securities			(21,316)
Other	(7,737)	5,059	(755)	4,930
Changes in operating assets and liabilities:
Accounts receivable	(43,087)	17,995	(93,832)	21,399
Inventories	(5,211)	2,359	(68)	(3,451)
Prepaid expenses and other current assets	(7,813)	(2,164)	(2,186)	3,072
Accounts payable	16,808	22,277	6,499	(8,019)
Accrued liabilities	21,397	63,450	32,325	66,450
Income taxes payable	920	(2,929)	(13,673)	2,148
Deferred revenue	(587)	(18)	(1,049)	(758)
Net cash provided by operating activities	173,707	110,924	486,693	264,590
Cash Flows From Investing Activities
Acquisition of businesses, net of cash acquired	(409,056)	308,982	(969,323)	308,982
Acquisition of intangible assets	(12,237)	(1,000)	(323,122)	(61,245)
Proceeds from sales and maturities of marketable securities		2,000	86,639	6,965
Purchases of marketable securities	(11,745)		(81,087)
Purchases of property, plant and equipment	(9,584)	(1,037)	(43,563)	(7,531)
Proceeds from sale of assets		6,422		14,964
Net cash (used in) provided by investing activities	(442,622)	315,367	(1,330,456)	262,135
Cash Flows From Financing Activities
Issuance of long-term debt			2,139,688
Repayment of long-term debt	(11,088)		(986,088)	(12,500)
Repurchase of common shares	(74,556)		(574,120)
Repurchase of convertible debt	(202,587)		(541,600)
Borrowings under credit facilities	690,000		790,000
Cash settlement of written call options	(66,864)		(66,864)
Acquisition of noncontrolling interest	(28,515)		(28,515)
Payment of employee withholding tax upon vesting of share-based awards	(2,477)		(57,155)
Tax benefits from stock options exercised	2,042		33,658
Proceeds from exercise of stock options	4,847	4,474	34,209	7,272
Financing costs paid	(11,777)		(31,590)
Cash dividends paid		(15,064)		(43,566)
Net cash provided by (used in) financing activities	299,025	(10,590)	711,623	(48,794)
Effect of exchange rate changes on cash and cash equivalents	(14,496)	387	(7,570)	260
Net increase (decrease) in cash and cash equivalents	15,614	416,088	(139,710)	478,191
Cash and cash equivalents, beginning of period	238,945	176,566	394,269	114,463
Cash and cash equivalents, end of period	254,559	592,654	254,559	592,654
Non-Cash Investing and Financing Activities
Acquisition of Valeant, equity issued		(3,880,301)		(3,880,301)
Acquisition of businesses, contingent consideration at fair value			397,150
Settlement of convertible debt, equity issued			(892,000)
Cash dividends declared but unpaid		$ (15,078)		$ (15,078)